The Procter & Gamble Company provided earnings guidance for the year 2023. P&G reduced its guidance range for fiscal 2023 all-in sales to be down 3% to down 1% versus the prior fiscal year. The Company maintained its outlook for organic sales growth in the range of 3% to 5%.

Foreign exchange is now expected to be a 6% headwind to all-in sales growth for the fiscal year. P&G maintained its outlook for fiscal 2023 diluted net earnings per share growth in the range of in-line to up 4% versus fiscal 2022 EPS of $5.81. The Company added that given increased foreign exchange impacts, it now expects EPS results to be towards the low end of the fiscal year guidance range.